Hi Lef, cheers mate.
Regarding the comparison, I was more so pointing out that various rerates can occur long before commercialization or even reg approval stage as shown with others, RAP is a good example and was a good performer in med tech space, not so much saying they're comparable companies or same field etc
I wouldn't imagine many denying the amazing value EMV represents.
-
- There are more pages in this discussion • 2,830 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
-0.020(1.14%) |
Mkt cap ! $147.9M | |||
| Open | High | Low | Value | Volume |
| $1.75 | $1.78 | $1.72 | $50.18K | 28.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2900 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.76 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| EMV (ASX) Chart |